Terms: = Prostate cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
30 results:
1. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
[TBL] [Abstract] [Full Text] [Related]
2. Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.
Axiaris G; Ioannou A; Papoutsaki M; Marinos L; Liontos M; Michopoulos S; Zampeli E
F1000Res; 2022; 11():424. PubMed ID: 37867623
[TBL] [Abstract] [Full Text] [Related]
3. A novel rapid detection method for a single-nucleotide substitution mutation derived from canine urothelial and prostatic carcinoma cells present in small amounts in urine sediments.
Okumura S; Ohsato Y
PLoS One; 2023; 18(9):e0286229. PubMed ID: 37733700
[TBL] [Abstract] [Full Text] [Related]
4. Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
Cancrini F; Osman N; Doizi S; Guillot-Tantay C; Hüsch T; Illiano E; Tutolo M; Tienza A; Culha MG; Vale L; Raison N; Herve F; Grande P; Roupret M; Phé V
Minerva Urol Nephrol; 2023 Apr; 75(2):163-171. PubMed ID: 36999836
[TBL] [Abstract] [Full Text] [Related]
5. Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients.
Singh N; Khatib J; Chiu CY; Lin J; Patel TS; Liu-Smith F
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833272
[TBL] [Abstract] [Full Text] [Related]
6. Prior Thyroid and Nonthyroid cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid cancer.
Chen YH; Cabanillas M; Sperling J; Xu L; Goswami M; Maniakas A; Williams MD; Lai SY; Busaidy N; Dadu R; Zafereo ME; Wang JR
Thyroid; 2023 Mar; 33(3):321-329. PubMed ID: 36511380
[No Abstract] [Full Text] [Related]
7. Clinical and histopathological features of bladder cancer following radiotherapy for prostate cancer: A comparative study.
Scherñuk J; González MI; Vecchio F; Alfieri AG; Tobia IP; Tejerizo JC; Favre GA
Urol Oncol; 2022 Nov; 40(11):492.e1-492.e6. PubMed ID: 35945111
[TBL] [Abstract] [Full Text] [Related]
8. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer.
Arnold P; Penaloza-Ramos MC; Adedokun L; Rees S; Lockhat M; Spary L; Watkins A; Gnanapragasam V; Crabb SJ
Sci Rep; 2021 Nov; 11(1):22151. PubMed ID: 34772971
[TBL] [Abstract] [Full Text] [Related]
10. Trends in Testosterone Therapy use in prostate cancer Survivors in the United States.
Chen T; Li S; Eisenberg ML
J Sex Med; 2021 Aug; 18(8):1346-1353. PubMed ID: 34303630
[TBL] [Abstract] [Full Text] [Related]
11. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract] [Full Text] [Related]
12. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
Lee J; Yang SW; Jin L; Lee CL; Lee JY; Shin JH; Lim JS; Song KH
BMC Cancer; 2021 Apr; 21(1):472. PubMed ID: 33910525
[TBL] [Abstract] [Full Text] [Related]
13. Novel Noninvasive Diagnostics.
Wiley C; Wise CF; Breen M
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):781-791. PubMed ID: 31280902
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.
Zhou J; Gou Z; Wu R; Yuan Y; Yu G; Zhao Y
Skeletal Radiol; 2019 Dec; 48(12):1915-1924. PubMed ID: 31127357
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic Value of Circulating miR-324 for prostate cancer.
Jin YY; Tong SQ; Tong M
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969074
[TBL] [Abstract] [Full Text] [Related]
16. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.
Nicolatou-Galitis O; Kouri M; Papadopoulou E; Vardas E; Galiti D; Epstein JB; Elad S; Campisi G; Tsoukalas N; Bektas-Kayhan K; Tan W; Body JJ; Migliorati C; Lalla RV;
Support Care Cancer; 2019 Feb; 27(2):383-394. PubMed ID: 30353228
[TBL] [Abstract] [Full Text] [Related]
17. Depression Treatment Among Elderly Medicare Beneficiaries With Incident Cases of cancer and Newly Diagnosed Depression.
Alwhaibi M; Madhavan S; Bias T; Kelly K; Walkup J; Sambamoorthi U
Psychiatr Serv; 2017 May; 68(5):482-489. PubMed ID: 28045347
[TBL] [Abstract] [Full Text] [Related]
18. Fast Diagnostics of braf Mutations in Biopsies from Malignant Melanoma.
Huber F; Lang HP; Glatz K; Rimoldi D; Meyer E; Gerber C
Nano Lett; 2016 Sep; 16(9):5373-7. PubMed ID: 27490749
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of Vitronectin Expression in prostate cancer and the Clinical Significance of the Association of Vitronectin Expression with prostate Specific Antigen in Detecting prostate cancer.
Niu Y; Zhang L; Bi X; Yuan S; Chen P
Urol J; 2016 Mar; 13(1):2527-32. PubMed ID: 26945657
[TBL] [Abstract] [Full Text] [Related]
20. Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for cancer: A Cluster Randomized Controlled Trial.
Murphy DR; Wu L; Thomas EJ; Forjuoh SN; Meyer AN; Singh H
J Clin Oncol; 2015 Nov; 33(31):3560-7. PubMed ID: 26304875
[TBL] [Abstract] [Full Text] [Related]
[Next]
